Author:
Helleberg Hans,Bjelke Mads,Damholt Birgitte Bentz,Pedersen Palle Jacob,Rasmussen Michael Højby
Reference23 articles.
1. Somapacitan, a once-weekly reversible albumin-binding GH derivative, in children with GH deficiency: a randomized dose-escalation trial;Battelino;Clin. Endocrinol. (Oxf),2017
2. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations;Christiansen;Eur. J. Endocrinol.,2016
3. Effect of kidney or hepatic impairment on the pharmacokinetics and pharmacodynamics of somapacitan: two Open-Label, Parallel-Group trials;Damholt;Clin. Pharmacokinet,2021
4. Metabolite technology: qualitative and quantitative;Dear,2016
5. European Medicines Agency, 2012. Guideline on clinical investigation of medicinal products in the treatment or prevention of diabetes mellitus.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献